HEALTH

Novel Stent Promises to Reduce Long-Term Failure

WASHINGTON — A variety of stent designs have tried and failed to reduce the number of stent-related adverse events over time, but now a new device with a unique design has shown some initial promise in addressing that weakness. A single-blind randomized trial of the DynamX Coronary Bioadaptor (Elixir Medical…

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button